MCTS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.355200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.497400E-01
Normal-vs-Stage2
5.818800E-01
Normal-vs-Stage3
6.403000E-01
Normal-vs-Stage4
5.912000E-01
Stage1-vs-Stage2
1.699830E-01
Stage1-vs-Stage3
3.062000E-01
Stage1-vs-Stage4
2.098800E-01
Stage2-vs-Stage3
6.102600E-01
Stage2-vs-Stage4
7.247000E-01
Stage3-vs-Stage4
9.292800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.671600E-01
Normal-vs-AfricanAmerican
5.895400E-01
Normal-vs-Asian
7.178400E-01
Caucasian-vs-AfricanAmerican
5.099400E-01
Caucasian-vs-Asian
8.860400E-01
AfricanAmerican-vs-Asian
3.445800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.845000E-01
Normal-vs-Female
5.997200E-01
Male-vs-Female
6.546400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.770000E-01
Normal-vs-Age(41-60Yrs)
9.416000E-01
Normal-vs-Age(61-80Yrs)
4.240600E-01
Normal-vs-Age(81-100Yrs)
8.641800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.517400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.156980E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.498200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.618450E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.395400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.961600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.829800E-01
Normal-vs-Daily Drinker
7.033600E-01
Normal-vs-Weekly Drinker
3.921400E-01
Normal-vs-Occasional Drinker
7.025000E-01
Normal-vs-Social Drinker
8.845000E-01
Non Drinker-vs-Daily Drinker
6.821800E-01
Non Drinker-vs-Weekly Drinker
5.061000E-01
Non Drinker-vs-Occasional Drinker
5.232000E-02
Non Drinker-vs-Social Drinker
4.676600E-01
Daily Drinker-vs-Weekly Drinker
3.121400E-01
Daily Drinker-vs-Occasional Drinker
1.229780E-01
Daily Drinker-vs-Social Drinker
7.066200E-01
Weekly Drinker-vs-Occasional Drinker
3.162500E-02
Weekly Drinker-vs-Social Drinker
2.398600E-01
Occasional Drinker-vs-Social Drinker
3.274200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.136400E-01
Normal-vs-Grade 2
6.074200E-01
Normal-vs-Grade 3
5.545200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.416200E-01
Grade 1-vs-Grade 3
4.985600E-01
Grade 1-vs-Grade 4
2.136400E-01
Grade 2-vs-Grade 3
1.667210E-01
Grade 2-vs-Grade 4
6.074200E-01
Grade 3-vs-Grade 4
5.545200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.466800E-01
Normal-vs-NonDiabetic
7.434600E-01
Diabetic-vs-NonDiabetic
1.311220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.207800E-01
Normal-vs-NoPancreatitis
6.270600E-01
Pancreatitis-vs-NoPancreatitis
4.504000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.237600E-01
Normal-vs-N1
5.840200E-01
N0-vs-N1
4.378200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.077200E-01
Normal-vs-TP53-NonMutant
8.732000E-01
TP53-Mutant-vs-TP53-NonMutant
8.665900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
